Studies on the accessibility barrier of NADH to cytochromes b in pigeon-heart mitochondria.
D000255:Adenosine Triphosphate / Q000494:pharmacology; D000818:Animals; D000968:Antimycin A / Q000494:pharmacology; D010856:Columbidae; D003580:Cytochromes / Q000378:metabolism*; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D007700:Kinetics; D008293:Malates / Q000378:metabolism; D008931:Mitochondria, Muscle / Q000187:drug effects / Q000201:enzymology*; D009206:Myocardium / Q000032:analysis / Q000166:cytology* / Q000201:enzymology; D009243:NAD / Q000378:metabolism*; D009285:Naphthoquinones / Q000494:pharmacology; D010084:Oxidation-Reduction; D010100:Oxygen / Q000032:analysis; D010539:Permeability; D010619:Phenazines / Q000494:pharmacology; D010758:Phosphorus / Q000032:analysis; D012402:Rotenone / Q000494:pharmacology; D013386:Succinates / Q000378:metabolism; D014451:Ubiquinone / Q000302:isolation & purification
D003580:Cytochromes; D008293:Malates; D009285:Naphthoquinones; D010619:Phenazines; D013386:Succinates; D012402:Rotenone; D009243:NAD; D014451:Ubiquinone; D010758:Phosphorus; D000968:Antimycin A; D000255:Adenosine Triphosphate; D010100:Oxygen